ADAPTIR
Live / Applied — Third extension granted (statement of use) (as of 24 Mar 2026)
What this means for you
Not registered yet, but its 07 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98304066
- Mark type
- Stylized text
- Filed
- 07 Dec 2023
- Published for opposition
- 13 Aug 2024
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 001 — Chemicals: Therapeutic protein molecules used in the manufacture of pharmaceuticals and biologically-derived medical preparations
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances, namely, polypeptides, antibodies, and antibody derivatives, for use in the treatment of autoimmune disorders and conditions, and cancer
Owner
- Aptevo Research and Development LLC, Seattle, WA, US
- Aptevo Research and Development LLC, Seattle, WA, US
Prosecution history
- 25 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Mar 2026 — SOU EXTENSION 3 GRANTED
- 24 Mar 2026 — SOU EXTENSION 3 FILED
- 24 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2025 — SOU EXTENSION 2 GRANTED
- 08 Oct 2025 — SOU EXTENSION 2 FILED
- 08 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Apr 2025 — SOU EXTENSION 1 GRANTED
- 08 Apr 2025 — SOU EXTENSION 1 FILED
- 08 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Aug 2024 — PUBLISHED FOR OPPOSITION